4//SEC Filing
Krassner Stuart Mitchell 4
Accession 0001209191-19-033233
CIK 0000831547other
Filed
May 28, 8:00 PM ET
Accepted
May 29, 5:00 PM ET
Size
15.2 KB
Accession
0001209191-19-033233
Insider Transaction Report
Form 4
Krassner Stuart Mitchell
Director
Transactions
- Exercise/Conversion
Common Stock, $0.001 par value
2019-05-24$6.09/sh+5,071$30,882→ 73,015 total - Sale
Common Stock, $0.001 par value
2019-05-24$7.94/sh−5,071$40,264→ 67,944 total - Exercise/Conversion
Common Stock, $0.001 par value
2019-05-28$6.09/sh+44,929$273,618→ 112,873 total - Sale
Common Stock, $0.001 par value
2019-05-28$8.00/sh−37,385$299,080→ 75,488 total - Exercise/Conversion
Stock Option Exercise (Right to Buy)
2019-05-24−5,071→ 44,929 totalExercise: $6.09From: 2012-06-26Exp: 2019-06-26→ Common Stock (5,071 underlying) - Exercise/Conversion
Stock Option Exercise (Right to Buy)
2019-05-28−44,929→ 0 totalExercise: $6.09From: 2012-06-26Exp: 2019-06-26→ Common Stock (44,929 underlying)
Footnotes (3)
- [F1]This transaction represents an open market sale of a portion of the expiring stock options exercised on this Form 4 to satisfy the Reporting Person's payment of the exercise price and the taxes associated with such exercise.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.94 to $7.965, inclusive. The reporting person undertakes to provide to Spectrum Pharmaceuticals, Inc., any security holder of Spectrum Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.995 to $8.01, inclusive. The reporting person undertakes to provide to Spectrum Pharmaceuticals, Inc., any security holder of Spectrum Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Documents
Issuer
SPECTRUM PHARMACEUTICALS INC
CIK 0000831547
Entity typeother
Related Parties
1- filerCIK 0001311636
Filing Metadata
- Form type
- 4
- Filed
- May 28, 8:00 PM ET
- Accepted
- May 29, 5:00 PM ET
- Size
- 15.2 KB